Dana Fletcher

profile image

Dana Fletcher serves as Medical and Technical Writer for Hart Clinical Consultants (HCC), providing technical content for HCC’s online presence. With more than 20 years’ experience in medical research in corporate and academic environments, and extensive experience with medical devices in cardiology, vascular surgery, infectious disease, and transfusion medicine, as well as experience with therapeutic integrative medicine modalities, Ms. Fletcher brings exceptional expertise and valuable insight to her writing for HCC.

In the past, Ms. Fletcher was Clinical Affairs Manager for Terumo BCT, where she managed all aspects of US clinical trial operations for new technologies in pathogen reduction of transfusion products. Before Terumo BCT, Ms. Fletcher worked for Abbott Vascular as Senior Clinical Research Associate for the Vessel Closure program, and led a team as Clinical Project Manager for the Carotid Stent and Embolic Protection program.

Before joining Abbott Vascular, Ms. Fletcher held several positions with Ischemia Technologies in Arvada, Colorado, including Manager of Clinical Development, Technical Services Specialist, and Clinical Affairs Associate. Early in her career, she was a Patent Investigator and Laboratory Research Associate with Biostar, Inc., in Boulder, Colorado, which specialized in point of care in vitro diagnostics for infectious disease testing.
Ms. Fletcher is the owner of Evida Clinical Consulting, an independent consulting firm primarily engaged in medical and regulatory writing, data analysis, and project management.

Ms. Fletcher holds a Master of Arts degree in Biology (Cell Immunology focus) from the University of Colorado at Denver and a Bachelor of Science degree in Biology from The Pennsylvania State University. She is currently working on her Doctorate degree in Health Services Research in the Colorado School of Public Health at the Anschutz Medical Campus in Denver, Colorado, with an expected graduation date in 2018.